Author: Dr. Shaun Larsen

People suffering from the more serious form of age-related macular degeneration known as wet AMD lose central vision when abnormal blood vessels sprout and leak fluid and blood into their retina, leading to further vision loss. Eye injections with medications such as bevacizumab or aflibercept can help control their growth; however, regular administration must occur…

Age-related macular degeneration (AMD) is an eye condition that affects central vision. This results in blurry or dimmed vision and makes reading, driving and seeing fine details difficult or impossible – although it does not usually lead to complete blindness. Doctors have developed medications to effectively treat wet AMD by stopping abnormal blood vessels from…

Some individuals with dry macular degeneration progress to wet form of the disease. This occurs when abnormal blood vessels grow and leak fluid under the retina, leading to blurry vision with straight lines appearing wavy and blind spots appearing. If you suspect wet AMD, it is crucial that you visit an eye doctor immediately to…

An NYU Langone doctor can use a dilated eye exam as the ideal way to assess whether macular degeneration has progressed or remains stable. During this painless procedure, your physician administers eye drops that dilate (widen) the pupils before taking pictures using optical coherence tomography of the back of your eye using OCT technology. Blurred…

AMD progression can be reduced through healthy eating habits, keeping out of direct sunlight by wearing protective eyewear such as sunglasses and hats, not smoking and scheduling regular eye exams – in addition to recent advances in treating wet macular degeneration. Treatment for wet AMD typically entails injecting drugs that prevent abnormal blood vessel growth…

Juvenile macular degeneration (JMD) is an eye condition which damages the macula, leading to central vision loss in one or both eyes. Symptoms usually emerge during childhood or early adolescence and may be accompanied by an Amsler grid. At an eye exam, your doctor will administer drops that widen your pupils to enable him or…

Patients suffering from wet age-related macular degeneration require regular injections of medication into their eye to avoid vision loss and must adhere to an intricate treatment schedule in order to keep vision intact. Maintaining such an regimen may prove challenging. Priyatham Mettu, a retina specialist with BrightFocus Chats, addressed questions regarding eye injections for wet…

Stargardt disease is an inherited disorder caused by mutations to the ABCA4 gene and manifests with central vision becoming blurry or distorted, without impacting peripheral vision. Eye doctors can detect this genetic disorder through an eye exam by noting elongated white, branching flecks in the retina caused by lipofuscin – a fatty substance that obscures…

AMD is one of the leading causes of vision loss among people aged 50 or above and can eventually lead to blindness in its advanced stages. Current treatments for wet AMD help protect patients’ vision by restricting blood vessel growth that causes neovascularization; however, these medications require monthly injections into the eye. Intravitreal Injections Each…

One dose of anti-VEGF drug Aflibercept (Eylea) typically costs from $1,850 – $2,200 retail while bevacizumab (Avastin) typically ranges from $55 retail. Genetic testing could result in a net financial return of $260 million per additional patient receiving early treatment for NVAMD. What is the Cost of Treatment for Wet AMD? The leading cause of…